Evidence map›Paper›PMID 33686074›Full record

ReviewNPJ Parkinson's disease2021

How COVID-19 will boost remote exercise-based treatment in Parkinson's disease: a narrative review.

Agnes Langer, Lucia Gassner, Anna Flotz, Sebastian Hasenauer, Jakob Gruber, Laurenz Wizany, Rochus Pokan, Walter Maetzler, Heidemarie Zach

Registry-linked trialOpen access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in NPJ Parkinson's disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07457710 (Enhancing Parkinson's Disease Rehabilitation Through Remote Haptic Guidance), which is not on this map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07457710 narecruitingnot on this mapstarted 2026, after this paper: background citation

Enhancing Parkinson's Disease Rehabilitation Through Remote Haptic Guidance: Field Study

TypeinterventionalSponsorVirginia Polytechnic Institute and State UniversityRan2026 to 2027Enrolled20ConditionsParkinson's Disease (PD)ArmsHaptic device, Non-haptic device
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. LSVT® BIG versus progressive structured mobility training through synchronous telerehabilitation in Parkinson's disease: A randomized controlled trial.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Agnes LangerDepartment of Neurology, Medical University of Vienna, Vienna, Austria. agnes.langer@meduniwien.ac.at.ORCID http://orcid.org/0000-0001-9932-0474
Lucia GassnerDepartment of Neurology, Medical University of Vienna, Vienna, Austria.
Anna FlotzDepartment of Neurology, Medical University of Vienna, Vienna, Austria.
Sebastian HasenauerDepartment of Neurology, Medical University of Vienna, Vienna, Austria.
Jakob GruberDepartment of Neurology, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0001-5915-618X
Laurenz WizanyDepartment of Neurology, Medical University of Vienna, Vienna, Austria.
Rochus PokanDepartment of Sport Physiology, Institute of Sports Sciences, University of Vienna, Vienna, Austria.
Walter MaetzlerDepartment of Neurology, University Medical Centre Schleswig-Holstein, Kiel University, Kiel, Germany.ORCID http://orcid.org/0000-0002-5945-4694
Heidemarie ZachDepartment of Neurology, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0003-3622-3831
Medical University of Vienna · ATUniversity of Vienna · ATChristian-Albrechts-Universität zu Kiel · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The lack of physical exercise during the COVID-19 pandemic-related quarantine measures is challenging, especially for patients with Parkinson's disease (PD). Without regular exercise not only patients, but also nursing staff and physicians soon noticed a deterioration of motor and non-motor symptoms. Reduced functional mobility, increased falls, increased frailty, and decreased quality of life were identified as consequences of increased sedentary behavior. This work overviews the current literature on problems of supplying conventional physiotherapy and the potential of telerehabilitation, allied health services, and patient-initiated exercise for PD patients during the COVID-19 period. We discuss recent studies on approaches that can improve remote provision of exercise to patients, including telerehabilitation, motivational tools, apps, exergaming, and virtual reality (VR) exercise. Additionally, we provide a case report about a 69-year-old PD patient who took part in a 12-week guided climbing course for PD patients prior to the pandemic and found a solution to continue her climbing training independently with an outdoor rope ladder. This case can serve as a best practice example for non-instructed, creative, and patient-initiated exercise in the domestic environment in difficult times, as are the current. Overall, many recent studies on telemedicine, telerehabilitation, and patient-initiated exercises have been published, giving rise to optimism that facilitating remote exercise can help PD patients maintain physical mobility and emotional well-being, even in phases such as the COVID-19 pandemic. The pandemic itself may even boost the need to establish comprehensive and easy-to-do telerehabilitation programs.

Identifiers

PMID33686074
PMCPMC7940641
OpenAlexW3134123914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.